Orbis Investment Management (US)’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
Other funds holding CELG
OAG
Orbis Investment Management (US)'s CELG Position: Q4 2018 in Review
Orbis Investment Management (US) increased its Celgene Corp (CELG) stake by 59% in Q4 2018, buying an estimated $3.77M and bringing the position to 137,538 shares worth $8.81M. The position accounts for 8.84% of the portfolio, ranked #3.
Orbis Investment Management (US) first reported a position in CELG in Q2 2014 and has held it in 17 quarters since. 1,317 funds tracked by Wall St. Rank hold CELG as of Q4 2018.
- Orbis Investment Management (US) held 137,538 shares of Celgene Corp worth $8.81M as of Q4 2018.
- Orbis Investment Management (US) bought 51,125 Celgene Corp shares in Q4 2018, an estimated $3.77M.
- Celgene Corp made up 8.84% of Orbis Investment Management (US)'s portfolio in Q4 2018, its #3 holding.
- Orbis Investment Management (US) first reported a position in Celgene Corp in Q2 2014 and has held it in 17 quarters since.
- 1,317 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2018.
Based on Orbis Investment Management (US)'s 13F filing for Q4 2018, filed 14 Feb 2019.